Systemic versus local regulation of vitamin D
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
PURPOSE OF REVIEW: New clinical data and technical advances challenge the long-held belief that the kidney is the predominant organ for vitamin D synthesis and degradation. This review highlights recent discoveries in systemic and local vitamin D regulation and their potential to influence future development of novel treatment concepts. RECENT FINDINGS: New clinical studies of calcifediol supplementation in anephric patients and in chronic kidney disease provide evidence for significant extra-renal vitamin D production. The clinical findings are supported by recent laboratory-based studies that utilize new technologies and mouse models. These studies identify the spleen and other organs as sites of vitamin D production, capable of compensating for a loss of kidney production in mice. The importance of local vitamin D metabolism is further underlined by the finding that secondary hyperparathyroidism in a model of chronic kidney disease could be attenuated by reducing vitamin D inactivation exclusively in the intestines. SUMMARY: Recent tissue-specific investigations of vitamin D metabolism identified several physiologically relevant and potentially targetable tissues beyond the kidney. These findings may provide the basis for novel treatments in kidney disease and other vitamin D-associated disorders with wider therapeutic windows than current approaches that act on the kidneys.